Wexford Capital LP Sangamo Therapeutics, Inc Transaction History

Wexford Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 15, 2024	BUY	$0.3 - $0.63 $13,635 - $28,633	45,450 New	45,450 $24,000
Q3 2018 Nov 14, 2018	SELL	$13.05 - $19.05 $1.67 Million - $2.43 Million	-127,800 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$13.9 - $19.8 $1.78 Million - $2.53 Million	127,800 New	127,800 $1.82 Million

113

57.8M

576K

1.17M

Ticker SGMO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 156,552,992
Market Cap $182M
Description
Sangamo Therapeutics, Inc., a clinical-stage biotechnology company, focuses on translating science into genomic medicines that transform patients' lives using platform technologies in gene therapy, cell therapy, genome editing, and genome regulation. The company offers zinc finger protein (ZFP), a technology platform for making zinc finger nucle...

Get notified when there are updates to the investment portfolio of Wexford Capital LP, based on Form 13F filings with the SEC.

Stay updated on Wexford Capital LP with notifications on news.